Acumen Pharmaceuticals, Inc.

US$0.22As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ABOSHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (55.23%)
Div yield —
ROE (162.72%)
Biotechnology
Beta (5Y) 0.45
PE TTM —
TSR TTM (89.89%)
Mkt cap US$16.17M
ROIC (70.78%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.253
13.19%
131.01%
Hold 5|9|10|8|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
(1.10%)
1.12%
(0.63%)
14.02%
Revenue$M
0.931
0.973
0.966
0.975
6.46%
9.73%
3.53%
6.49%
Peers (US$16.17M)
Cap (US$)
PE
15.57M
—
Capital
TTM
5Y
10Y
Leveragex
0.681
0.132
0.091
EBIT/Intx
1.197
0.471
0.482
Own earn%
(33.79)
(15.24)
7.84
Sh yield%
29.05
21.22
22.27
Owners
Insiders/Inst%
13.57
34.62
Short interest%
1.67
SBC / revenue%
2.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
1–10
$1 testx
0.1
Incr. ROIC%
18